These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 852370

  • 1. Neuroleptic dosage, duration, and tardive dyskinesia.
    Allen RE, Stimmel GL.
    Dis Nerv Syst; 1977 May; 38(5):385-7. PubMed ID: 852370
    [No Abstract] [Full Text] [Related]

  • 2. Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model [proceedings].
    Rubovits R.
    Psychopharmacol Bull; 1977 Jan; 13(1):49-50. PubMed ID: 402011
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. On guidelines for maximum dosages.
    Shader RI, Elkins R, Ciraulo D, Salzman C.
    Am J Psychiatry; 1978 Apr; 135(4):499-500. PubMed ID: 637154
    [No Abstract] [Full Text] [Related]

  • 5. The pathophysiology of tardive dyskinesia.
    Klawans HL, Carvey P, Tanner CM, Goetz CG.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phenytoin potentiation of neuroleptic-induced dyskinesias.
    Sethi KD, Hitri A, Diamond BI.
    Mov Disord; 1990 Apr; 5(4):325-7. PubMed ID: 2147979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic-induced tardive dyskinesia.
    Jenner P, Marsden CD.
    Acta Psychiatr Belg; 1987 Apr; 87(5):566-98. PubMed ID: 2897761
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coexisting tardive dyskinesia and parkinsonism: a case report.
    De Fraites EG, Davis KL, Berger PA.
    Biol Psychiatry; 1977 Apr; 12(2):267-72. PubMed ID: 857938
    [Abstract] [Full Text] [Related]

  • 14. A therapeutic approach to tardive dyskinesia.
    Fahn S.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [Abstract] [Full Text] [Related]

  • 15. A survey of tardive dyskinesia in psychiatric outpatients.
    Asnis GM, Leopold MA, Duvoisin RC, Schwartz AH.
    Am J Psychiatry; 1977 Dec; 134(12):1367-70. PubMed ID: 335900
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic approaches to neuroleptic-induced tardive dyskinesias.
    Klawans HL.
    Res Publ Assoc Res Nerv Ment Dis; 1976 Dec; 55():447-57. PubMed ID: 1005908
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of neuroleptic induced tardive dyskinesia with cyproheptadine.
    Kurata K, Hosokawa K, Koshino Y.
    J Neurol; 1977 Jul 20; 215(4):295-8. PubMed ID: 70522
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G, Cole JO, Schniebolk S, Salomon M.
    J Clin Psychiatry; 1987 Sep 20; 48(9):359-62. PubMed ID: 2887550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.